Mackay I G, Muir A L, Watson M L
Br J Clin Pharmacol. 1984 May;17(5):513-9. doi: 10.1111/j.1365-2125.1984.tb02383.x.
In eight normotensive male volunteers indomethacin decreased both the peak urine flow rate and total sodium excreted within 1 h of an intravenous dose of frusemide. Resting effective renal plasma flow and glomerular filtration rate were unchanged by indomethacin, but the increase in both parameters after frusemide was inhibited. The early increase in plasma renin activity after frusemide was inhibited by indomethacin. Indomethacin decreased urinary excretion of PGE by 80% and the increase after frusemide was abolished. The urinary excretion of a metabolite of systemic PGI2 was unaltered in the 40-60 min period following frusemide. The early haemodynamic effects of frusemide are likely to be prostaglandin mediated, but there was no evidence of any change in systemic PGI2 synthesis after frusemide.
在8名血压正常的男性志愿者中,静脉注射速尿后1小时内,消炎痛降低了尿流峰值速率和钠排泄总量。消炎痛对静息时的有效肾血浆流量和肾小球滤过率没有影响,但抑制了速尿给药后这两个参数的增加。消炎痛抑制了速尿给药后血浆肾素活性的早期升高。消炎痛使前列腺素E的尿排泄量减少80%,并消除了速尿给药后的增加。在速尿给药后的40 - 60分钟内,全身前列环素2代谢产物的尿排泄量没有改变。速尿的早期血流动力学效应可能由前列腺素介导,但没有证据表明速尿给药后全身前列环素2合成有任何变化。